Global Fiberoptic Phototherapy Equipment Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Fiberoptic Phototherapy Equipment Market Size

• The global fiberoptic phototherapy equipment market size was valued at USD 140.58 million in 2025 and is expected to reach USD 203.00 million by 2033, at a CAGR of 4.70% during the forecast period
• The market growth is largely fueled by rising adoption of phototherapy solutions particularly fiberoptic in both neonatal care and dermatological applications, driven by technological improvements, increased healthcare investments, and growing demand for non-invasive therapies
• Furthermore, increased awareness and demand for compact, portable, and efficient phototherapy devices, along with expansion of healthcare infrastructure especially in emerging economies, are accelerating the uptake of fiberoptic phototherapy equipment, thereby significantly boosting the industry's growth

Fiberoptic Phototherapy Equipment Market Analysis

• Fiberoptic phototherapy equipment, providing targeted light therapy for conditions such as neonatal jaundice and dermatological treatments, is becoming an essential component in modern healthcare settings due to its non-invasive nature, portability, and enhanced treatment efficiency
• The escalating demand for fiberoptic phototherapy devices is primarily driven by increasing awareness of neonatal care, technological advancements in compact and energy-efficient phototherapy systems, and growing adoption in hospitals, clinics, and homecare settings
• North America dominated the fiberoptic phototherapy equipment market with the largest revenue share of 39.2% in 2025, supported by advanced healthcare infrastructure, high prevalence of neonatal jaundice, and a strong presence of key industry players developing innovative and efficient phototherapy solutions
• Asia-Pacific is expected to be the fastest-growing region in the fiberoptic phototherapy equipment market during the forecast period due to rising birth rates, increasing healthcare investments, and growing adoption of modern medical devices in emerging economies
• Neonatal Jaundice Management segment dominated the market with a share of 52.9% in 2025, driven by its critical role in managing newborn jaundice and the rising preference for fiberoptic systems that allow continuous treatment without restricting infant mobility

Report Scope and Fiberoptic Phototherapy Equipment Market Segmentation

Fiberoptic Phototherapy Equipment Market Trends

Advancements in Portable and Home-Use Phototherapy Devices

• A significant and accelerating trend in the global fiberoptic phototherapy equipment market is the development of portable and home-use devices, allowing continuous neonatal or dermatological treatment without hospital confinement
  • For instance, the Bilisoft Phototherapy System enables parents to administer safe, effective jaundice treatment at home while monitoring therapy progress via a smartphone app
• Modern devices incorporate LED and fiberoptic technologies to improve light efficiency, reduce heat emission, and enhance treatment comfort for infants and patients
• Fiberoptic phototherapy systems are increasingly integrated with monitoring tools that track treatment duration and intensity, ensuring optimal care without manual intervention
• Integration with digital health platforms and mobile apps allows caregivers to receive alerts, track patient progress, and adjust treatment remotely
• Manufacturers are focusing on ergonomic designs, lightweight materials, and flexible light pads to increase usability and patient comfort during therapy
• This trend towards more convenient, user-friendly, and home-capable phototherapy devices is reshaping healthcare delivery, allowing hospitals and clinics to reduce patient load
• The demand for portable and home-use fiberoptic phototherapy equipment is growing rapidly across both hospital and homecare settings, as caregivers increasingly prioritize ease of use, treatment flexibility, and continuous care

Fiberoptic Phototherapy Equipment Market Dynamics

Driver

Increasing Prevalence of Neonatal Jaundice and Dermatological Conditions

• The rising incidence of neonatal jaundice and growing awareness of effective treatment options is a major driver for the fiberoptic phototherapy equipment market
  • For instance, in March 2025, GE Healthcare launched an advanced LED-based phototherapy unit for neonatal care, targeting hospitals in North America and Asia-Pacific
• Healthcare providers are increasingly adopting fiberoptic systems due to their non-invasive nature, high treatment efficacy, and ability to allow simultaneous parental interaction with the infant
• Furthermore, increasing prevalence of skin disorders such as psoriasis and vitiligo is driving demand for fiberoptic phototherapy devices in dermatology clinics worldwide
• The convenience of portable systems, continuous treatment options, and improved patient compliance are key factors propelling adoption across hospital, clinic, and homecare settings
• The trend towards compact, energy-efficient, and easy-to-use phototherapy devices, along with rising awareness campaigns, further contributes to market growth
• Expansion of neonatal care infrastructure in emerging economies and government initiatives promoting early treatment of jaundice are further accelerating market demand
• Innovation in multi-functional devices that combine phototherapy with other neonatal care features is creating new opportunities for market players

Restraint/Challenge

High Device Cost and Regulatory Compliance Requirements

• The relatively high cost of advanced fiberoptic phototherapy equipment poses a challenge for widespread adoption, especially in developing regions and small healthcare facilities
  • For instance, specialized LED fiberoptic units can cost multiple times more than conventional phototherapy lamps, limiting accessibility in price-sensitive markets
• Strict regulatory standards for medical devices, including safety certifications and clinical trial requirements, can delay product launches and increase compliance costs
• Smaller manufacturers often face hurdles in meeting FDA, CE, or other international regulatory requirements, impacting market entry and expansion
• While prices are gradually decreasing due to technological advancements and economies of scale, the perceived premium for high-efficiency phototherapy systems can still hinder adoption in budget-constrained settings
• Overcoming these challenges through cost optimization, streamlined regulatory approvals, and awareness programs for caregivers will be crucial for sustained market growth
• Limited trained personnel to operate advanced phototherapy systems in remote or rural areas further restricts market penetration
• Potential device malfunctions or inconsistencies in light intensity can raise safety concerns, requiring stringent quality control and maintenance protocols

Fiberoptic Phototherapy Equipment Market Scope

The market is segmented on the basis of product, application, modality, and end use.

• By Product

On the basis of product, the fiberoptic phototherapy equipment market is segmented into conventional phototherapy equipment, LED phototherapy equipment, and fiberoptic phototherapy equipment. The fiberoptic phototherapy equipment segment dominated the market with the largest revenue share of 44.5% in 2025, driven by its enhanced safety, portability, and reduced heat exposure compared to conventional lamps. Fiberoptic devices allow localized treatment, minimizing disruption to the patient’s daily activities while maintaining effective therapy. Hospitals and neonatal care units prefer fiberoptic systems for their flexibility in use and high treatment efficiency. The demand is also fueled by technological advancements such as LED integration and improved fiberoptic light delivery systems. In addition, these devices are suitable for both hospital and homecare settings, providing continuous treatment for neonates or dermatology patients. Their non-invasive nature and low risk of side effects further support widespread adoption.

The LED phototherapy equipment segment is anticipated to witness the fastest growth rate of 22.3% from 2026 to 2033, driven by rising awareness about energy-efficient and environmentally friendly treatment options. LED-based phototherapy offers higher light intensity with lower power consumption, longer lifespan, and reduced maintenance compared to conventional systems. The growing adoption of LED phototherapy in dermatology clinics and homecare is also driving its rapid growth. In addition, the compact design and portability of LED systems make them appealing for hospitals with space constraints. Manufacturers are continuously innovating LED devices with integrated monitoring and smartphone connectivity, enhancing usability. The increasing preference for eco-friendly medical devices further accelerates market expansion for LED phototherapy solutions.

• By Application

On the basis of application, the market is segmented into skin disease treatment and neonatal jaundice management. The neonatal jaundice management segment dominated the market with a share of 52.9% in 2025, due to the high prevalence of jaundice in newborns worldwide and the critical need for timely intervention. Hospitals and clinics prioritize fiberoptic and LED phototherapy devices for neonates as they allow continuous care without separating the infant from parents. The segment’s growth is supported by rising birth rates in emerging economies and increasing healthcare investments. Government initiatives promoting neonatal care and awareness campaigns about early jaundice treatment further boost demand. Healthcare professionals prefer these devices due to their non-invasive operation, precise light dosing, and reduced side effects compared to traditional phototherapy lamps. Continuous advancements in device portability and monitoring features also contribute to segment dominance.

The skin disease treatment segment is expected to witness the fastest CAGR from 2026 to 2033, driven by increasing prevalence of dermatological conditions such as psoriasis, vitiligo, and eczema globally. Fiberoptic and LED phototherapy devices are gaining traction in dermatology clinics for their precise, localized treatment capabilities. The growing preference for non-invasive treatment options and homecare phototherapy is also fueling rapid adoption. Technological developments such as combination therapies and adjustable light intensity are further boosting growth. In addition, expanding awareness among patients and dermatologists regarding phototherapy benefits contributes to segment acceleration. Rising demand for compact and portable units for home use adds further impetus to market growth.

• By Modality

On the basis of modality, the market is segmented into full body phototherapy and partial body phototherapy. The full body phototherapy segment dominated the market with the largest revenue share in 2025, attributed to its effectiveness in treating widespread neonatal jaundice and large-area skin conditions. Hospitals and clinics prefer full body systems for simultaneous treatment of multiple areas, reducing therapy duration and improving patient throughput. The segment is further supported by innovations in LED and fiberoptic technology, which provide uniform light distribution and minimize heat exposure. Full body devices are also preferred for in-patient neonatal care and dermatology wards due to their reliability and operational efficiency. Moreover, the safety features incorporated in modern systems ensure minimal side effects and continuous monitoring.

The partial body phototherapy segment is anticipated to witness the fastest growth from 2026 to 2033, driven by the increasing adoption of targeted therapy for localized skin conditions and homecare applications. Partial body systems are portable, lightweight, and allow caregivers to treat specific areas without disrupting patient mobility. Dermatology clinics and home users prefer these devices for convenience, cost-effectiveness, and focused treatment outcomes. Technological innovations such as flexible light pads and adjustable intensity settings further enhance the usability of partial body systems. The rising trend of home-based phototherapy and outpatient care is expected to accelerate market growth for this segment.

• By End Use

On the basis of end use, the market is segmented into hospitals and clinics, and homecare. The hospitals and clinics segment dominated the market with the largest revenue share in 2025, driven by the concentration of neonatal care units and dermatology departments in medical facilities. Hospitals prefer fiberoptic and LED phototherapy devices for their clinical efficiency, safety, and ability to support multiple patients simultaneously. The segment benefits from continuous technological advancements, staff training programs, and government healthcare initiatives promoting neonatal and dermatological care. Moreover, hospitals have higher budgets to adopt advanced phototherapy solutions, enhancing market penetration. Established medical device manufacturers focus heavily on hospital contracts, further reinforcing segment dominance.

The homecare segment is expected to witness the fastest CAGR from 2026 to 2033, fueled by rising awareness among parents and patients about at-home phototherapy benefits. Portable fiberoptic and LED systems allow safe, continuous treatment without hospital visits, improving compliance and convenience. Increasing adoption of digital health platforms and mobile apps enables caregivers to monitor therapy remotely, enhancing safety and efficacy. The trend toward home-based care, particularly for neonatal jaundice and chronic dermatological conditions, is driving rapid growth. Rising disposable incomes and easy availability of user-friendly devices further support the expansion of the homecare segment.

Fiberoptic Phototherapy Equipment Market Regional Analysis

• North America dominated the fiberoptic phototherapy equipment market with the largest revenue share of 39.2% in 2025, supported by advanced healthcare infrastructure, high prevalence of neonatal jaundice, and a strong presence of key industry players developing innovative and efficient phototherapy solutions
• Healthcare providers and parents in the region prioritize safe, efficient, and non-invasive treatment options for neonatal jaundice and dermatological conditions, increasing the demand for fiberoptic phototherapy systems
• This strong adoption is further supported by well-established hospitals and clinics, availability of skilled medical professionals, and the presence of key industry players developing innovative and portable phototherapy devices, establishing fiberoptic systems as a preferred choice for both clinical and homecare applications

U.S. Fiberoptic Phototherapy Equipment Market Insight

The U.S. fiberoptic phototherapy equipment market captured the largest revenue share of 79% in 2025 within North America, driven by advanced neonatal care infrastructure and high adoption of modern medical devices. Hospitals and homecare providers are increasingly prioritizing safe, non-invasive treatment options for neonatal jaundice and dermatological conditions. The growing preference for portable and LED-integrated phototherapy systems, combined with digital monitoring capabilities, further propels the market. Moreover, rising awareness among parents and healthcare professionals regarding early intervention benefits significantly contributes to market expansion.

Europe Fiberoptic Phototherapy Equipment Market Insight

The Europe fiberoptic phototherapy equipment market is projected to expand at a substantial CAGR throughout the forecast period, primarily fueled by increasing awareness of neonatal care and dermatological treatment options. Stringent healthcare regulations, coupled with rising urbanization, are fostering adoption across hospitals and clinics. European healthcare providers are drawn to energy-efficient, safe, and technologically advanced phototherapy systems. The market is witnessing significant growth across neonatal units and dermatology clinics, with fiberoptic and LED devices being incorporated into both new facilities and facility upgrades.

U.K. Fiberoptic Phototherapy Equipment Market Insight

The U.K. fiberoptic phototherapy equipment market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising concerns about neonatal jaundice and the need for effective dermatological treatments. Hospitals and homecare services are adopting portable and LED-based phototherapy systems for convenience and treatment efficacy. The U.K.’s robust healthcare infrastructure, alongside a focus on patient safety and technological adoption, continues to stimulate market growth. Increased awareness campaigns and government initiatives promoting neonatal care are also key growth factors.

Germany Fiberoptic Phototherapy Equipment Market Insight

The Germany fiberoptic phototherapy equipment market is expected to expand at a considerable CAGR during the forecast period, supported by advanced healthcare facilities and increasing awareness of phototherapy benefits. Hospitals are adopting fiberoptic and LED systems for neonatal care and skin disease management due to their safety, portability, and treatment efficiency. Germany’s emphasis on innovation and sustainability promotes the adoption of energy-efficient phototherapy devices. Integration of these devices with monitoring systems and hospital workflows is becoming increasingly common, enhancing operational efficiency and patient care outcomes.

Asia-Pacific Fiberoptic Phototherapy Equipment Market Insight

The Asia-Pacific fiberoptic phototherapy equipment market is poised to grow at the fastest CAGR of 23% during the forecast period of 2026 to 2033, driven by rising birth rates, expanding healthcare infrastructure, and increasing awareness of neonatal care. Countries such as China, India, and Japan are witnessing rapid adoption of portable and LED-integrated phototherapy systems. Government initiatives promoting maternal and child health, along with improved affordability and availability of fiberoptic devices, are fueling market expansion. The region is also emerging as a hub for manufacturing phototherapy equipment, enhancing accessibility to hospitals and homecare providers.

Japan Fiberoptic Phototherapy Equipment Market Insight

The Japan fiberoptic phototherapy equipment market is gaining momentum due to the country’s advanced healthcare infrastructure, focus on neonatal care, and technological adoption. Hospitals and homecare providers are increasingly utilizing portable and LED-based fiberoptic systems to treat neonatal jaundice and skin conditions efficiently. Integration with digital monitoring and IoT-enabled devices supports continuous care and improved patient outcomes. Moreover, Japan’s aging population and high awareness of healthcare technologies are expected to further drive market demand in both residential and clinical settings.

India Fiberoptic Phototherapy Equipment Market Insight

The India fiberoptic phototherapy equipment market accounted for the largest revenue share in Asia-Pacific in 2025, attributed to rapid urbanization, expanding middle class, and increasing awareness of neonatal and dermatological care. Hospitals and clinics are investing in portable, LED-based fiberoptic systems for efficient treatment. Government programs promoting neonatal health, coupled with rising homecare adoption and availability of affordable devices, are key factors propelling the market. In addition, the presence of local manufacturers and growing acceptance of modern medical technologies further strengthen market growth.

Fiberoptic Phototherapy Equipment Market Share

The Fiberoptic Phototherapy Equipment industry is primarily led by well-established companies, including:

• GE HealthCare (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Natus Medical Incorporated (U.S.)
• ATOM MEDICAL Corp. (Japan)
• Drägerwerk AG & Co. KGaA (Germany)
• Phoenix Medical Systems Pvt. Ltd. (India)
• Herbert Waldmann GmbH & Co. KG (Germany)
• Solarc Systems, Inc. (U.S.)
• Medela AG (Switzerland)
• Ibis Medical Equipment and Systems Pvt. Ltd. (India)
• Nice Neotech Medical Systems Pvt. Ltd. (India)
• AVI Healthcare Pvt. Ltd. (India)
• Weyer GmbH (Germany)
• Beijing Julongsanyou Science & Technology Co., Ltd. (China)
• Zhengzhou Dison Instrument And Meter Co., Ltd. (China)
• Fanem Ltda. (Brazil)
• Novos Medical Systems (Turkey)
• Shvabe Zurich GmbH (Russia)
• National Biological Corporation (U.S.)
• Medtronic (Ireland)

What are the Recent Developments in Global Fiberoptic Phototherapy Equipment Market?

• In May 2025, a first‑in‑human pilot study demonstrated that a wearable phototherapy device Jauni was effective and safe for treating neonatal hyperbilirubinemia: in 10 out of 12 neonates phototherapy was successfully completed within 48 h with acceptable bilirubin reduction and good tolerance
• In March 2025, Drägerwerk AG expanded its neonatal care portfolio by launching a new software-based solution BiliPredics which combines rapid bilirubin screening (via its JM-105 jaundice meter) with LED phototherapy treatment (via its BiliLux phototherapy light), enabling integrated jaundice management with real-time bilirubin‑trend monitoring and electronic medical record (EMR) integration
• In November 2024, a multicenter clinical trial comparing a wrap-around fiberoptic phototherapy device BiliCocoon with standard overhead LED phototherapy in neonates with hyperbilirubinemia found that while BiliCocoon had slightly lower bilirubin‑reduction efficacy compared to overhead phototherapy (29% vs 38% decrease in TSB over 24h), it allowed longer uninterrupted light exposure and enabled (breast)feeding during therapy offering a potential trade‑off between convenience and efficacy
• In August 2024, an analysis in the industry highlighted that home‑based phototherapy (portable / flexible phototherapy devices) is expanding market potential mainly as an alternative to hospital treatment for jaundiced newborns, reducing hospital stays and making therapy feasible at home
• In October 2023, Philips Healthcare unveiled a new neonatal phototherapy device designed to improve treatment efficacy for jaundiced infants, with real‑time monitoring capabilities underlining a shift toward integrated, clinician‑friendly solutions in neonatal care

SKU-46315